Pulmatrix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pulmatrix and other ETFs, options, and stocks.About PULM
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J.
CEOPeter B. Ludlum
CEOPeter B. Ludlum
Employees2
Employees2
HeadquartersFramingham, Massachusetts
HeadquartersFramingham, Massachusetts
Founded2003
Founded2003
Employees2
Employees2
PULM Key Statistics
Market cap8.62M
Market cap8.62M
Price-Earnings ratio-1.39
Price-Earnings ratio-1.39
Dividend yield—
Dividend yield—
Average volume35.11K
Average volume35.11K
High today$3.65
High today$3.65
Low today$2.31
Low today$2.31
Open price$3.65
Open price$3.65
Volume220.05K
Volume220.05K
52 Week high$10.40
52 Week high$10.40
52 Week low$2.31
52 Week low$2.31
Stock Snapshot
Pulmatrix(PULM) stock is priced at $2.37, giving the company a market capitalization of 8.62M. It carries a P/E multiple of -1.39.
On 2025-12-22, Pulmatrix(PULM) stock moved within a range of $2.31 to $3.65. With shares now at $2.37, the stock is trading +2.6% above its intraday low and -35.1% below the session's peak.
Trading volume for Pulmatrix(PULM) stock has reached 220.05K, versus its average volume of 35.11K.
The stock's 52-week range extends from a low of $2.31 to a high of $10.40.
The stock's 52-week range extends from a low of $2.31 to a high of $10.40.
People also own
Based on the portfolios of people who own PULM. This list is generated using Robinhood data, and it’s not a recommendation.